Test your knowledge

This activity is intended to give you an opportunity to test your knowledge of the content contained in the infographics and other resources available on this portal. After submitting the quiz you will be given your score and additional information about the correct answer. Besides being a fun way to verify your understanding, the feedback is helpful to AGA to confirm the information was presented in an easy-to-understand manner.”

Submit response to see the correct answer and how others participants responded.

Which of the following is NOT an indirect cost? *
The biggest component of spend for inflammatory bowel disease in the US is for pharmaceuticals. True or False? *

Additional resources

Testimonials

  • Dana McCormick, RPh, FAMCP, Optum

    Senior Director, Pharmacy Advisory Services

    “I have seen the influence of specialty society guidelines on payors’ decisions. Other than randomized clinical trials, specialty societies are the first place payors go to get more information.”

  • Rocio Castrillon, MBA, @VoiceForIBD


    “I’ve often seen where a payor has the wrong contact information for the provider or perhaps the provider’s latest update says the approval is in ‘PA status’ and then somewhere in the timeline, it gets lost in the follow-up process. Patients are typically more aware of when prior authorizations aren’t going through due to immediate notifications and can oftentimes help do the follow-up work. Patients do tend to have more success with appeals when verbalizing the direct effects we are experiencing due to a delay in authorization. I believe having patients be able to do some of the follow-up allows for the opportunity for the patient to not only be proactive, but also not have to be sitting around waiting for an authorization to go through.”